Spinal Cord InjuryNCT02154412
Mechanisms of Arterial Hypotension in Chronic Spinal Cord Injury
A study testing Respiratory Training in people with Spinal Cord Injury, run by University of Louisville at 1 site in United States.
Trial summary
This clinical study is designed to investigate the mechanisms of blood pressure regulation and respiratory motor function affected by spinal cord injury (SCI). We hypothesize that impaired blood pressure regulation in individuals with chronic SCI can be improved by restoring respiratory motor function by using… Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Spinal Cord Injury
- What is being tested?
- Respiratory Training
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 1 participants
- Where
- 1 siteUnited States
- Study dates
- Jun 2011to 30 Apr 2019
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Non-progressive chronic Spinal Cord Injury (SCI)
- At least 18 years old
- Stable medical condition
- No diseases or conditions that would contraindicate the respiratory muscle training (RMT)
- Not ventilator-dependent for respiration
- At least 15%-deficit in pulmonary function outcome measures
- Orthostatic hypotension
Who cannot join
- Major cardiovascular or pulmonary disease
- Endocrine disorders
- Malignancy
- Pregnancy (no pregnancy test or birth control regimen will be required)
Trial locations and contacts
1 site in 1 country.
United States1 site
Frazier Rehabilitation and Neuroscience Institute
Louisville, Kentucky, 40202
About this study
This clinical study is designed to investigate the mechanisms of blood pressure regulation and respiratory motor function affected by spinal cord injury (SCI). We hypothesize that impaired blood pressure regulation in individuals with chronic SCI can be improved by restoring respiratory motor function by using Respiratory Motor Training (RMT).
Read the detailed description
Methods \& Procedures
Screening spirometry will be performed with patient sitting in his/her personal wheelchair using BreezeSuite System. Forced Vital Capacity (FVC) \& Forced Expiratory Volume in 1 second (FEV1) will be obtained \& expressed as the percent of the predicted value for each subject based on a database of neurologically intact individuals with no known pulmonary complaints that was derived based on gender, age, \& height. Three acceptable spirograms will be obtained \& the result of their best attempt will be used.
Screening Orthostatic Stress Test will be conducted in patient placed on the cardiac chair (Chair Hydraulics). The left hand will be placed in an arm sling \& kept at the level of the heart throughout the study. Continuous beat-to beat arterial blood pressure will be acquired from a finger cuff placed around the left middle or index finger (Portapres-2) in supine position \& when the participants is moved into the upright seated position. Supine positions will be maintained for 15 min. \& upright position will be maintained for 5 min. Baseline values in supine position will be recorded during the last 5-min period just before changing to the upright position. This test will be aborted if subjects become lightheaded or symptomatic of syncope.
Spirometry \& Respiratory Muscle Strength Tests: Standard spirometry will be performed in sitting position by using BreezeSuite System (MedGraphics). FVC \& FEV1 will be obtained. MP45-36-871-350 Differential Pressure Transducer with UPC 2100 PC card \& software (Validyne Engineering) will be used to measure the maximum inspiratory pressure (PImax) \& the maximum expiratory pressure (PEmax) in sitting position. The PImax will be measured during maximal inspiratory effort beginning at near residual volume \& PEmax will be measured during maximal expiratory effort starting from near total lung capacity. Subjects will be asked to use a three-way valve system with rubber tube as mouthpiece. The pressure meter incorporates a 1.5 mm diameter leak to prevent glottic closure \& to reduce buccal muscle contribution during measurements. The assessment will require a sharp, forceful effort be maintained for a minimum of 2 seconds. The maximum pressure will be taken as the highest value that sustained for one second. The maximum value from three maneuvers that varied by less than 20% will be averaged. Participants will be given specific instructions prior to the test \& will be verbally coached throughout the spirometry \& respiratory muscle strength maneuvers.
Orthostatic Stress Test:
Each participant will be tested in the morning in a quiet, temperature-controlled (~22o C) cardiovascular laboratory. Their diet will be restricted to exclude caffeine, alcohol \& foods that are high in fat on the evening prior to \& the morning of the study. Participants will be asked to empty their bladder before beginning the study. Continuous arterial BP will be acquired from a finger cuff placed around the left middle or index finger or thumb (Portapres-2;). The left hand will be placed in an arm sling \& kept at the level of the heart throughout the study. Manual arterial BP measurements will be taken at the beginning of the supine control period \& at the end of the recovery period with a digital blood pressure measurement device. A 3-lead ECG will be placed for ECG monitoring. Rib cage \& abdomen kinematics (respiratory kinematics) will be acquired using an inductive plethysmograph. Baseline recording for 15 min. will begin after a 5-minute rest period that will follow subject preparation. At the end of 15-minute recording in the supine position, participants will be passively moved into the upright seated position. This position will be maintained for 15 min. This test will be aborted if subjects become lightheaded or symptomatic of syncope. Hemodynamic variables will be acquired at 1000 Hz using ML880 PowerLab System. ECG, SBP \& DBP will be computed from continuous recording, \& all variables will be then down-sampled to 5Hz. Beat-to-beat SBP, DBP, RR-interval \& HR will be also calculated from acquired continuous BP \& ECG. All analyses will be done using Matlab. The Blood flow in the heart will be measured by Cardiac Ultrasound using standard equipment by placing a sensor above the heart.
Blood Catecholamines:
A butterfly catheter will be inserted into an antecubital vein during instrumentation to allow the collection of blood without additional stress to the participant. Eight milliliters of venous blood will be drawn from an antecubital vein at the end of 15-minute supine to assess baseline epinephrine \& norepinephrine levels. Blood draw will be repeated at 3 \& at the end of 15 min. of upright position to assess quick \& steady-state catecholamines responses to orthostatic stress.
Baroreflex evaluation: The last 5 min. of data acquired from each position will be used for further analysis. The beat-to-beat time series of SBP \& RR intervals will be scanned for three or more consecutive beats that independently contain increasing \& decreasing pressure (SBP+, SBP-) \& RR interval (RR+, RR-) with minimum 1 mmHg SBP, \& 4 ms RR interval thresholds. If an identified SBP sequence is followed by an identified RR sequence with delay of zero, one, or two beats, those SBP \& RR sequences will be assigned as coupled. Only coupled sequences with regression coefficient r>0.90 will be accepted as a baroreflex sequences (BRsq). The mean slope of all BRsq will be calculated \& taken as an estimation of baroreflex sensitivity (BRS, ms/mmHg). The numbers of beats involved in SBP ramps \& BRsq will be determined at each tilt position. The baroreflex effectiveness index (BEI) will be calculated as the ratio between the total number of BRsq \& the total number of SBP ramps.
sEMG protocol: Electrical impulses originate in regulatory neurons, carried via motor nerves, transmit through neuromuscular junction \& propagate throughout muscle membranes can be recorded by surface electromyography (sEMG).This physiological test is often relied upon during clinical pulmonary function testing \& in research, has been shown to be an accurate reflection of the contractile strength of the respiratory muscles.We will use a multi-muscle sEMG-based measure of motor output from the central nervous system recorded during voluntary motor tasks attempted in the supine position under strictly controlled conditions that was based on Brain Motor Control Assessment (BMCA) principles. The protocol consists of the following voluntary maneuvers followed by 5 min. of quiet breathing: deep breath, PImax task \& PEmax task. Each maneuver will be cued by an audible tone \& repeated three times. PImax \& PEmax during these tasks will be maintained for a minimum of 5 seconds. Airway pressure will be recorded simultaneously with sEMG using a three-way valve system with a pressure transducer as described above. Surface EMG recordings will be accomplished with pairs of recessed, FE9 silver-silver chloride cap surface electrodes (Grass Instruments, W Warwick, RI) centered over the muscle \& placed 3 cm apart for each muscle recorded. Skin will be prepared to reduce intra-electrode impedance. Right \& left upper portion of pectoralis (PEC), 6th intercostals (IC6), rectus abdominus (RA), \& obliquus abdominus (OBL) muscles will be recorded. The ground electrode will be placed over the acromion process. sEMG will be recorded using an Eclipse Neurological Workstation (Axon Systems Inc.). The incoming sEMG signals will be amplified with a gain of 500, filtered at 30-1000 Hz \& sampled at 2000 Hz.
Ultrasonic cardiac echography: Standard left ventricular echocardiograms in supine resting state will be obtained measuring end-diastolic diameter (Dd) \& the end-systolic diameter (Ds). Ten consecutive beats will be analyzed \& the mean will be used for cardiac output (Q) calculations: Q= (Dd)3- (DS)3x HR 35.
Respiratory Muscle Training:
During the training session, subjects will be seated in their personal wheelchair with an approximately 45° head-up tilt. A threshold Positive Expiratory Pressure Device \& a threshold Inspiratory Muscle Trainer with flanged mouthpiece will be used for a range of 20 to 41 cm H2O. These devices will be assembled together using a T-shaped connector (Airlife 001504). The participants will be instructed to perform maximal inspiratory \& expiratory efforts against a pressure load. During inhalation, the subjects will be instructed to initiate each breath from residual volume (RV) \& to sustain the effort until their lungs feel full. During exhalation, the subjects will be instructed to breathe from total lung capacity \& sustain their effort until their lungs feel empty. Participants will be asked to train 45 min. per day, 5 days per week, for 4 weeks. The training will be initiated with a load equal to 20% of their individual PImax \& PEmax with progressive increases as tolerated up to 40% of their baseline PImax or PEmax. The goal will be to have all patients training at 40% of PImax \& PEmax during the last week of the training. An interval training protocol will be used with patients performing six work sets, 5 min. in duration, separated by rest intervals lasting 1-3 min.. A research team member will monitor all training sessions.
Preliminary results showed that RMT will increase FVC, FEV1, PImax \& PEmax in experimental subjects compared to pre-training values. The biggest effect is expected for expiratory values (FEV1, \& PEmax). One reason for this might be the fact that expiratory function, the most limited after SCI, has bigger window for change. Our results showed that average increase of 8-9% with a sample size of 24-26 patients could reveal a significant difference with a power of 80-86% in all spirometrical values.
Aim 2. Improvement in the BP \& mechanisms associated with blood pressure changes were assessed using the low-frequency component of power spectral density of systolic (SBP) \& diastolic (DBP) blood pressure values \& amount of catecholamines measured in blood levels. Based on preliminary findings small changes are expected in the resting BP values after training. However, after training, the increase in SBP when position is changed to sit-up is expected to be strong with low variability. The calculations showed that even with n=20, the power will be 84% \& when n=24, it will be increased to 94%. Changes in DBP are expected to be lower with power of 80% for n=24. Similar values were obtained when low frequency modulations of SBP \& DBP were analyzed.
According to this analysis, number of subjects from 20 to 24 will result in significant increase with 87% power. The effectiveness \& sensitivity of the baroreflex both improved after training in the preliminary study. After training, in response to the orthostatic stress, a substantial increase in baroreflex responsiveness was obtained \& a power of 83% will result with a sample size of 24. The baroreflex sensitivity exhibited much higher variability. If variability remains high in the proposed study, the power of achieving a significant difference from pre-to post-training is 83% with a sample size of 28 patients.
However, a decrease in variability is very likely with a larger sample size \& the power increases to 86% with a sample of 24 patients with a 32% decrease in variability.
Based on the results of test-re-test recordings in 10 SCI subjects, the matched number of untrained subjects (n=12) will be enough to form a control group. The deviations from the means were found to be so low, that it would be impossible to reach significance with a reasonable sample size for this group.
- Conditions
- Spinal Cord Injury
- Being tested
- Respiratory Training
- Keywords
- Respiration, Motor control, Blood Pressure, Orthostatic Hypotension
- Medical subject headings
- Spinal Cord Injuries, Respiratory Aspiration, Hypotension, Orthostatic
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Respiratory TrainingOther
Assembled together using a T-shaped connector, a threshold Positive Expiratory Pressure Device (Respironics, Inc.) \& an Inspiratory Muscle Trainer (IMT, Respironics Inc.) with mouthpiece will be used. During inhalation, the subjects will initiate each breath from residual volume (RV) and to sustain the effort until their lungs feel full. During exhalation, the subjects will breathe from total lung capacity and sustain their effort until their lungs feel empty. Participants will be asked to train 45 minutes per day, 5 days per week, for 4 weeks. The training will be initiated with a load equal to 20% of their individual PImax and PEmax with progressive increases as tolerated up to 40% of their baseline PImax or PEmax.
| Study group | Role | What they receive |
|---|---|---|
| Respiratory training | Experimental | Subjects will be seated in own wheelchair with head-up tilt. Assembled together, a threshold Positive Expiratory Pressure Device (Respironics, Inc.) \& an Inspiratory Muscle Trainer (IMT, Respironics Inc.) with mouthpiece will be used. Subjects will perform maximal inspiratory and expiratory efforts against a pressure load. Participants will be asked to train 45 minutes per day, 5 days per week, for 4 weeks. The training will be initiated with a load equal to 20% of their individual PImax and PEmax with progressive increases as tolerated up to 40% of their baseline PImax or PEmax. Receives: Other: Respiratory Training |
| No respiratory training | No intervention | Participants will not participate in the respiratory muscle training. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Pulmonary function test
Standard spirometry measures in percent predicted values
Measured: Before and after 20 sessions of RMT
Secondary outcomes (2)
Blood pressure change measurement
Beat-to-beat blood pressure in mmHg
Measured: Before and after 20 sessions of RMT
Maximum airway pressure
Airway pressure in cm H2O
Measured: Before and after 20 sessions of RMT
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Jun 2014 (estimated)
- Study startJun 2011
- Primary completion30 Apr 2019
- Study completion30 Apr 2019
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (12)Papers the sponsor has linked to this study.
- Other trials for Spinal Cord InjuryStudies of the same condition, open and under way.
- More trials run by University of LouisvilleThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 1 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Louisville
- Sponsor type
- University, hospital or other
- Collaborators
- The Craig H. Neilsen Foundation
- Responsible party
- Principal investigator, Alexander V Ovechkin, MD, PhD, University of Louisville
- Investigators
- Alexander Ovechkin, PhD, Principal investigator, University of Louisville
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02154412
- Sponsor's protocol ID
- 11.0286 Ovechkin
- Status last verified
- Mar 2025
- First submitted
- 30 May 2014
- Last updated
- 7 Mar 2025
- Results posted
- No
- Data monitoring committee
- No
- Individual data sharing
- No
Publications
DeVivo MJ, Krause JS, Lammertse DP. Recent trends in mortality and causes of death among persons with spinal cord injury. Arch Phys Med Rehabil. 1999 Nov;80(11):1411-9. doi: 10.1016/s0003-9993(99)90252-6.
PubMed 10569435Krassioukov A. Autonomic function following cervical spinal cord injury. Respir Physiol Neurobiol. 2009 Nov 30;169(2):157-64. doi: 10.1016/j.resp.2009.08.003. Epub 2009 Aug 12.
PubMed 19682607Teasell RW, Arnold JM, Krassioukov A, Delaney GA. Cardiovascular consequences of loss of supraspinal control of the sympathetic nervous system after spinal cord injury. Arch Phys Med Rehabil. 2000 Apr;81(4):506-16. doi: 10.1053/mr.2000.3848.
PubMed 10768544Claydon VE, Krassioukov AV. Orthostatic hypotension and autonomic pathways after spinal cord injury. J Neurotrauma. 2006 Dec;23(12):1713-25. doi: 10.1089/neu.2006.23.1713.
PubMed 17184183Bernard PL, Mercier J, Varray A, Prefaut C. Influence of lesion level on the cardioventilatory adaptations in paraplegic wheelchair athletes during muscular exercise. Spinal Cord. 2000 Jan;38(1):16-25. doi: 10.1038/sj.sc.3100956.
PubMed 10762193Frankel HL, Coll JR, Charlifue SW, Whiteneck GG, Gardner BP, Jamous MA, Krishnan KR, Nuseibeh I, Savic G, Sett P. Long-term survival in spinal cord injury: a fifty year investigation. Spinal Cord. 1998 Apr;36(4):266-74. doi: 10.1038/sj.sc.3100638.
PubMed 9589527Garshick E, Kelley A, Cohen SA, Garrison A, Tun CG, Gagnon D, Brown R. A prospective assessment of mortality in chronic spinal cord injury. Spinal Cord. 2005 Jul;43(7):408-16. doi: 10.1038/sj.sc.3101729.
PubMed 15711609De Troyer A, Estenne M, Heilporn A. Mechanism of active expiration in tetraplegic subjects. N Engl J Med. 1986 Mar 20;314(12):740-4. doi: 10.1056/NEJM198603203141203.
PubMed 3951503Winslow C, Rozovsky J. Effect of spinal cord injury on the respiratory system. Am J Phys Med Rehabil. 2003 Oct;82(10):803-14. doi: 10.1097/01.PHM.0000078184.08835.01.
PubMed 14508412Laffont I, Durand MC, Rech C, De La Sotta AP, Hart N, Dizien O, Lofaso F. Breathlessness associated with abdominal spastic contraction in a patient with C4 tetraplegia: a case report. Arch Phys Med Rehabil. 2003 Jun;84(6):906-8. doi: 10.1016/s0003-9993(02)04898-0.
PubMed 12808547Walter JS, Sacks J, Othman R, Rankin AZ, Nemchausky B, Chintam R, Wheeler JS. A database of self-reported secondary medical problems among VA spinal cord injury patients: its role in clinical care and management. J Rehabil Res Dev. 2002 Jan-Feb;39(1):53-61.
PubMed 11926327Claydon VE, Steeves JD, Krassioukov A. Orthostatic hypotension following spinal cord injury: understanding clinical pathophysiology. Spinal Cord. 2006 Jun;44(6):341-51. doi: 10.1038/sj.sc.3101855. Epub 2005 Nov 22.
PubMed 16304564
Study at a glance
From the registry record, last updated by the sponsor on 7 Mar 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Mechanisms of Arterial Hypotension in Chronic Spinal Cord Injury
- ClinicalTrials.gov ID
- NCT02154412
- Acronym / sponsor ID
- 11.0286 Ovechkin
- Conditions
- Spinal Cord Injury
- Keywords
- Respiration, Motor control, Blood Pressure, Orthostatic Hypotension
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 1 participants (actual)
- Lead sponsor
- University of LouisvilleUniversity, hospital or other
- Collaborators
- The Craig H. Neilsen Foundation
- Study start
- Jun 2011 (actual)
- Primary completion
- 30 Apr 2019 (actual)
- Study completion
- 30 Apr 2019 (actual)
- First posted
- 3 Jun 2014 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This clinical study is designed to investigate the mechanisms of blood pressure regulation and respiratory motor function affected by spinal cord injury (SCI). We hypothesize that impaired blood pressure regulation in individuals with chronic SCI can be improved by restoring respiratory motor function by using Respiratory Motor Training (RMT).
Detailed description
Methods \& Procedures
Screening spirometry will be performed with patient sitting in his/her personal wheelchair using BreezeSuite System. Forced Vital Capacity (FVC) \& Forced Expiratory Volume in 1 second (FEV1) will be obtained \& expressed as the percent of the predicted value for each subject based on a database of neurologically intact individuals with no known pulmonary complaints that was derived based on gender, age, \& height. Three acceptable spirograms will be obtained \& the result of their best attempt will be used.
Screening Orthostatic Stress Test will be conducted in patient placed on the cardiac chair (Chair Hydraulics). The left hand will be placed in an arm sling \& kept at the level of the heart throughout the study. Continuous beat-to beat arterial blood pressure will be acquired from a finger cuff placed around the left middle or index finger (Portapres-2) in supine position \& when the participants is moved into the upright seated position. Supine positions will be maintained for 15 min. \& upright position will be maintained for 5 min. Baseline values in supine position will be recorded during the last 5-min period just before changing to the upright position. This test will be aborted if subjects become lightheaded or symptomatic of syncope.
Spirometry \& Respiratory Muscle Strength Tests: Standard spirometry will be performed in sitting position by using BreezeSuite System (MedGraphics). FVC \& FEV1 will be obtained. MP45-36-871-350 Differential Pressure Transducer with UPC 2100 PC card \& software (Validyne Engineering) will be used to measure the maximum inspiratory pressure (PImax) \& the maximum expiratory pressure (PEmax) in sitting position. The PImax will be measured during maximal inspiratory effort beginning at near residual volume \& PEmax will be measured during maximal expiratory effort starting from near total lung capacity. Subjects will be asked to use a three-way valve system with rubber tube as mouthpiece. The pressure meter incorporates a 1.5 mm diameter leak to prevent glottic closure \& to reduce buccal muscle contribution during measurements. The assessment will require a sharp, forceful effort be maintained for a minimum of 2 seconds. The maximum pressure will be taken as the highest value that sustained for one second. The maximum value from three maneuvers that varied by less than 20% will be averaged. Participants will be given specific instructions prior to the test \& will be verbally coached throughout the spirometry \& respiratory muscle strength maneuvers.
Orthostatic Stress Test:
Each participant will be tested in the morning in a quiet, temperature-controlled (~22o C) cardiovascular laboratory. Their diet will be restricted to exclude caffeine, alcohol \& foods that are high in fat on the evening prior to \& the morning of the study. Participants will be asked to empty their bladder before beginning the study. Continuous arterial BP will be acquired from a finger cuff placed around the left middle or index finger or thumb (Portapres-2;). The left hand will be placed in an arm sling \& kept at the level of the heart throughout the study. Manual arterial BP measurements will be taken at the beginning of the supine control period \& at the end of the recovery period with a digital blood pressure measurement device. A 3-lead ECG will be placed for ECG monitoring. Rib cage \& abdomen kinematics (respiratory kinematics) will be acquired using an inductive plethysmograph. Baseline recording for 15 min. will begin after a 5-minute rest period that will follow subject preparation. At the end of 15-minute recording in the supine position, participants will be passively moved into the upright seated position. This position will be maintained for 15 min. This test will be aborted if subjects become lightheaded or symptomatic of syncope. Hemodynamic variables will be acquired at 1000 Hz using ML880 PowerLab System. ECG, SBP \& DBP will be computed from continuous recording, \& all variables will be then down-sampled to 5Hz. Beat-to-beat SBP, DBP, RR-interval \& HR will be also calculated from acquired continuous BP \& ECG. All analyses will be done using Matlab. The Blood flow in the heart will be measured by Cardiac Ultrasound using standard equipment by placing a sensor above the heart.
Blood Catecholamines:
A butterfly catheter will be inserted into an antecubital vein during instrumentation to allow the collection of blood without additional stress to the participant. Eight milliliters of venous blood will be drawn from an antecubital vein at the end of 15-minute supine to assess baseline epinephrine \& norepinephrine levels. Blood draw will be repeated at 3 \& at the end of 15 min. of upright position to assess quick \& steady-state catecholamines responses to orthostatic stress.
Baroreflex evaluation: The last 5 min. of data acquired from each position will be used for further analysis. The beat-to-beat time series of SBP \& RR intervals will be scanned for three or more consecutive beats that independently contain increasing \& decreasing pressure (SBP+, SBP-) \& RR interval (RR+, RR-) with minimum 1 mmHg SBP, \& 4 ms RR interval thresholds. If an identified SBP sequence is followed by an identified RR sequence with delay of zero, one, or two beats, those SBP \& RR sequences will be assigned as coupled. Only coupled sequences with regression coefficient r>0.90 will be accepted as a baroreflex sequences (BRsq). The mean slope of all BRsq will be calculated \& taken as an estimation of baroreflex sensitivity (BRS, ms/mmHg). The numbers of beats involved in SBP ramps \& BRsq will be determined at each tilt position. The baroreflex effectiveness index (BEI) will be calculated as the ratio between the total number of BRsq \& the total number of SBP ramps.
sEMG protocol: Electrical impulses originate in regulatory neurons, carried via motor nerves, transmit through neuromuscular junction \& propagate throughout muscle membranes can be recorded by surface electromyography (sEMG).This physiological test is often relied upon during clinical pulmonary function testing \& in research, has been shown to be an accurate reflection of the contractile strength of the respiratory muscles.We will use a multi-muscle sEMG-based measure of motor output from the central nervous system recorded during voluntary motor tasks attempted in the supine position under strictly controlled conditions that was based on Brain Motor Control Assessment (BMCA) principles. The protocol consists of the following voluntary maneuvers followed by 5 min. of quiet breathing: deep breath, PImax task \& PEmax task. Each maneuver will be cued by an audible tone \& repeated three times. PImax \& PEmax during these tasks will be maintained for a minimum of 5 seconds. Airway pressure will be recorded simultaneously with sEMG using a three-way valve system with a pressure transducer as described above. Surface EMG recordings will be accomplished with pairs of recessed, FE9 silver-silver chloride cap surface electrodes (Grass Instruments, W Warwick, RI) centered over the muscle \& placed 3 cm apart for each muscle recorded. Skin will be prepared to reduce intra-electrode impedance. Right \& left upper portion of pectoralis (PEC), 6th intercostals (IC6), rectus abdominus (RA), \& obliquus abdominus (OBL) muscles will be recorded. The ground electrode will be placed over the acromion process. sEMG will be recorded using an Eclipse Neurological Workstation (Axon Systems Inc.). The incoming sEMG signals will be amplified with a gain of 500, filtered at 30-1000 Hz \& sampled at 2000 Hz.
Ultrasonic cardiac echography: Standard left ventricular echocardiograms in supine resting state will be obtained measuring end-diastolic diameter (Dd) \& the end-systolic diameter (Ds). Ten consecutive beats will be analyzed \& the mean will be used for cardiac output (Q) calculations: Q= (Dd)3- (DS)3x HR 35.
Respiratory Muscle Training:
During the training session, subjects will be seated in their personal wheelchair with an approximately 45° head-up tilt. A threshold Positive Expiratory Pressure Device \& a threshold Inspiratory Muscle Trainer with flanged mouthpiece will be used for a range of 20 to 41 cm H2O. These devices will be assembled together using a T-shaped connector (Airlife 001504). The participants will be instructed to perform maximal inspiratory \& expiratory efforts against a pressure load. During inhalation, the subjects will be instructed to initiate each breath from residual volume (RV) \& to sustain the effort until their lungs feel full. During exhalation, the subjects will be instructed to breathe from total lung capacity \& sustain their effort until their lungs feel empty. Participants will be asked to train 45 min. per day, 5 days per week, for 4 weeks. The training will be initiated with a load equal to 20% of their individual PImax \& PEmax with progressive increases as tolerated up to 40% of their baseline PImax or PEmax. The goal will be to have all patients training at 40% of PImax \& PEmax during the last week of the training. An interval training protocol will be used with patients performing six work sets, 5 min. in duration, separated by rest intervals lasting 1-3 min.. A research team member will monitor all training sessions.
Preliminary results showed that RMT will increase FVC, FEV1, PImax \& PEmax in experimental subjects compared to pre-training values. The biggest effect is expected for expiratory values (FEV1, \& PEmax). One reason for this might be the fact that expiratory function, the most limited after SCI, has bigger window for change. Our results showed that average increase of 8-9% with a sample size of 24-26 patients could reveal a significant difference with a power of 80-86% in all spirometrical values.
Aim 2. Improvement in the BP \& mechanisms associated with blood pressure changes were assessed using the low-frequency component of power spectral density of systolic (SBP) \& diastolic (DBP) blood pressure values \& amount of catecholamines measured in blood levels. Based on preliminary findings small changes are expected in the resting BP values after training. However, after training, the increase in SBP when position is changed to sit-up is expected to be strong with low variability. The calculations showed that even with n=20, the power will be 84% \& when n=24, it will be increased to 94%. Changes in DBP are expected to be lower with power of 80% for n=24. Similar values were obtained when low frequency modulations of SBP \& DBP were analyzed.
According to this analysis, number of subjects from 20 to 24 will result in significant increase with 87% power. The effectiveness \& sensitivity of the baroreflex both improved after training in the preliminary study. After training, in response to the orthostatic stress, a substantial increase in baroreflex responsiveness was obtained \& a power of 83% will result with a sample size of 24. The baroreflex sensitivity exhibited much higher variability. If variability remains high in the proposed study, the power of achieving a significant difference from pre-to post-training is 83% with a sample size of 28 patients.
However, a decrease in variability is very likely with a larger sample size \& the power increases to 86% with a sample of 24 patients with a 32% decrease in variability.
Based on the results of test-re-test recordings in 10 SCI subjects, the matched number of untrained subjects (n=12) will be enough to form a control group. The deviations from the means were found to be so low, that it would be impossible to reach significance with a reasonable sample size for this group.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Respiratory training | Experimental | Other: Respiratory TrainingSubjects will be seated in own wheelchair with head-up tilt. Assembled together, a threshold Positive Expiratory Pressure Device (Respironics, Inc.) \& an Inspiratory Muscle Trainer (IMT, Respironics Inc.) with mouthpiece will be used. Subjects will perform maximal inspiratory and expiratory efforts against a pressure load. Participants will be asked to train 45 minutes per day, 5 days per week, for 4 weeks. The training will be initiated with a load equal to 20% of their individual PImax and PEmax with progressive increases as tolerated up to 40% of their baseline PImax or PEmax. |
| No respiratory training | No intervention | –Participants will not participate in the respiratory muscle training. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- Non-progressive chronic Spinal Cord Injury (SCI)
- At least 18 years old
- Stable medical condition
- No diseases or conditions that would contraindicate the respiratory muscle training (RMT)
- Not ventilator-dependent for respiration
Key exclusion criteria (4 listed)
- Major cardiovascular or pulmonary disease
- Endocrine disorders
- Malignancy
- Pregnancy (no pregnancy test or birth control regimen will be required)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Respiratory TrainingAssembled together using a T-shaped connector, a threshold Positive Expiratory Pressure Device (Respironics, Inc.) \& an Inspiratory Muscle Trainer (IMT, Respironics Inc.) with mouthpiece will be used. During inhalation, the subjects will initiate each breath from residual volume (RV) and to sustain the effort until their lungs feel full. During exhalation, the subjects will breathe from total lung capacity and sustain their effort until their lungs feel empty. Participants will be asked to train 45 minutes per day, 5 days per week, for 4 weeks. The training will be initiated with a load equal to 20% of their individual PImax and PEmax with progressive increases as tolerated up to 40% of their baseline PImax or PEmax. | Other | Respiratory training |
Primary outcome
Pulmonary function test
Time frame: Before and after 20 sessions of RMT
Standard spirometry measures in percent predicted values
2 secondary outcomes
Blood pressure change measurement
Time frame: Before and after 20 sessions of RMT
Maximum airway pressure
Time frame: Before and after 20 sessions of RMT
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Mar 2025.
- Background: PubMed 10569435DeVivo MJ, Krause JS, Lammertse DP. Recent trends in mortality and causes of death among persons with spinal cord injury. Arch Phys Med Rehabil. 1999 Nov;80(11):1411-9. doi: 10.1016/s0003-9993(99)90252-6.
- Background: PubMed 19682607Krassioukov A. Autonomic function following cervical spinal cord injury. Respir Physiol Neurobiol. 2009 Nov 30;169(2):157-64. doi: 10.1016/j.resp.2009.08.003. Epub 2009 Aug 12.
- Background: PubMed 10768544Teasell RW, Arnold JM, Krassioukov A, Delaney GA. Cardiovascular consequences of loss of supraspinal control of the sympathetic nervous system after spinal cord injury. Arch Phys Med Rehabil. 2000 Apr;81(4):506-16. doi: 10.1053/mr.2000.3848.
- Background: PubMed 17184183Claydon VE, Krassioukov AV. Orthostatic hypotension and autonomic pathways after spinal cord injury. J Neurotrauma. 2006 Dec;23(12):1713-25. doi: 10.1089/neu.2006.23.1713.
- Background: PubMed 10762193Bernard PL, Mercier J, Varray A, Prefaut C. Influence of lesion level on the cardioventilatory adaptations in paraplegic wheelchair athletes during muscular exercise. Spinal Cord. 2000 Jan;38(1):16-25. doi: 10.1038/sj.sc.3100956.
- Background: PubMed 9589527Frankel HL, Coll JR, Charlifue SW, Whiteneck GG, Gardner BP, Jamous MA, Krishnan KR, Nuseibeh I, Savic G, Sett P. Long-term survival in spinal cord injury: a fifty year investigation. Spinal Cord. 1998 Apr;36(4):266-74. doi: 10.1038/sj.sc.3100638.
- Background: PubMed 15711609Garshick E, Kelley A, Cohen SA, Garrison A, Tun CG, Gagnon D, Brown R. A prospective assessment of mortality in chronic spinal cord injury. Spinal Cord. 2005 Jul;43(7):408-16. doi: 10.1038/sj.sc.3101729.
- Background: PubMed 3951503De Troyer A, Estenne M, Heilporn A. Mechanism of active expiration in tetraplegic subjects. N Engl J Med. 1986 Mar 20;314(12):740-4. doi: 10.1056/NEJM198603203141203.
- Background: PubMed 14508412Winslow C, Rozovsky J. Effect of spinal cord injury on the respiratory system. Am J Phys Med Rehabil. 2003 Oct;82(10):803-14. doi: 10.1097/01.PHM.0000078184.08835.01.
- Background: PubMed 12808547Laffont I, Durand MC, Rech C, De La Sotta AP, Hart N, Dizien O, Lofaso F. Breathlessness associated with abdominal spastic contraction in a patient with C4 tetraplegia: a case report. Arch Phys Med Rehabil. 2003 Jun;84(6):906-8. doi: 10.1016/s0003-9993(02)04898-0.
- Background: PubMed 11926327Walter JS, Sacks J, Othman R, Rankin AZ, Nemchausky B, Chintam R, Wheeler JS. A database of self-reported secondary medical problems among VA spinal cord injury patients: its role in clinical care and management. J Rehabil Res Dev. 2002 Jan-Feb;39(1):53-61.
- Background: PubMed 16304564Claydon VE, Steeves JD, Krassioukov A. Orthostatic hypotension following spinal cord injury: understanding clinical pathophysiology. Spinal Cord. 2006 Jun;44(6):341-51. doi: 10.1038/sj.sc.3101855. Epub 2005 Nov 22.
- Individual participant dataSharing planned: No
Related trials for Spinal Cord Injury
Recruiting
MyHand-SCI: An Active Hand Orthosis for Spinal Cord Injury
Spinal Cord Injuries, Tetraplegia
Recruiting
Clinical Outcome Assessment for AT & BCI
Spinal Cord Injury, ALS (Amyotrophic Lateral Sclerosis)
Recruiting
Transcutaneous Spinal Cord Stimulation Combined With 4-Aminopyridine and Intensive Rehabilitation in SCI
Spinal Cord Injuries
Not yet recruiting
Evaluating the Effect of the Zeen Mobility Device on Clinical Practicality, Safety, and Impact (Via Assessments of Walking, Standing Tolerance, Balance, Endurance, Effort, and Participation in Daily Tasks) in an Outpatient Rehabilitation Setting for Individuals With Mobility Impairments.
Stroke, Parkinson's Disease (PD)
RecruitingPhase 3
A Trial Investigating the Efficacy and Safety of NVG-291 in Subjects With Chronic Spinal Cord Injury
Chronic Spinal Cord Injury
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Alexander Ovechkin, PhD principal investigator
University of Louisville
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Respiratory Training in people with Spinal Cord Injury, run by University of Louisville at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 7 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Pulmonary function test (time frame: Before and after 20 sessions of RMT). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02154412, which also lists 12 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Mar 2025.